SA
Sign upLog In

Syndax Pharmaceuticals Inc (SNDX)

Cost of Revenue

$6.37M

TTM · Period ending: · USD

SNDX logo

SNDX Cost of Revenue

Latest reported$6.37M
SNDX TTM Cost of Revenue ($0.00 → $6.37M)
High-resolution chart · PNG

SNDX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Syndax Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,369,000
4,440,000
2,692,000
4,264,000
2,164,000
885,000
0
0
0
0
0
0
0
0
0
121,000
121,000
121,000
121,000
1,000
1,000
1,000
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
600,000
1,200,000
1,200,000
1,200,000
600,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.